Evicenter
Vabysmo (faricimab-svoa), All indications
Manufacturer
Genentech, Inc.
Prescribing information
Vabysmo (opens in a new tab)
Questions
66
Last updated

All questions

Safety: Vabysmo (faricimab-svoa), all indications

12 questions · 3 sources

Side effects

What are the most common side effects of Vabysmo?

Note: The 15% and 8% figures in the first passage match the DME columns of Table 1. In the wet AMD trials (TENAYA and LUCERNE) the Table 1 rates were 3% for cataract and 7% for conjunctival hemorrhage. Table 1 columns are VABYSMO in AMD (N=664), DME (N=1,262), and RVO (N=641), then aflibercept in AMD (N=662), DME (N=625), and RVO (N=635), in that order; the AMD columns are the wet AMD trials (TENAYA and LUCERNE).

Can patients develop antibodies to Vabysmo?

Warnings

Who should not receive Vabysmo (contraindications)?

Can Vabysmo cause allergic reactions?

Can Vabysmo cause eye infection (endophthalmitis) or retinal detachment?

Does Vabysmo raise eye pressure (IOP)?

Can Vabysmo cause retinal vasculitis or retinal vascular occlusion?

Note: The last passage is the footnote (¶) to the statement before it.

Monitoring

What monitoring is needed after a Vabysmo injection?

Safety

What symptoms should patients report after a Vabysmo injection?

Can patients drive after a Vabysmo injection?

Has Vabysmo been tested for cancer risk (carcinogenicity)?

How do I report Vabysmo side effects?